BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators
O. Castellanet, F. Ahmad, Y. Vinik, G. B. Mills, B. H. Habermann, J.-P. H. Borg, S. Lev, F. Lamballe, F. Maina
This study shows that blocking BCL-XL makes TNBC cells vulnerable to CDK1/2/4 inhibitors, but not other cell cycle regulators, through synergistic effects on survival and apoptosis pathways.
bioRxiv · Mar 16, 2021Cancer Biology